Diabetes and Endocrinology Topic Homepage

Learning Zones

,LALD Header

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre is intended to provide healthcare professionals with accurate disease awareness and treatment information for patients with this condition.

LAL deficiency is an autosomal recessive lysosomal storage disorder resulting in marked lysosomal accumulation of cholesteryl esters and triglycerides. LAL deficiency has multi-organ involvement including the liver, spleen, and cardiovascular system. The two major phenotypes of this condition are a rapidly progressive form in infancy (formerly known as Wolman disease) and a later-onset progressive form in children and adults (formerly known as cholesteryl ester storage disease, CESD).

Users of this educational resource can expect to find clinical content arranged within three main sections:

Disease Awareness: including epidemiology, pathophysiology, genotypic presentation, diagnosis, prognosis and more…

Treatment: presents the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency

Resources: useful external links, events calendar and a video channel with short expert video discussions on topics such as diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

,Adipositas-Lernzentrum

Das Adipositas-Lernzentrum enthält klinische Informationen und Materialien für Gesundheitsexperten, die mit der Behandlung und dem Management von adipösen oder übergewichtigen Patienten befasst sind.

Hier finden Sie ein Wissenszentrum mit Informationen über die Epidemiologie, Pathophysiologie, klinischen Leitlinien, Bewertungs- und Behandlungsoptionen, Präventionsmethoden u. v. m. Andere Bereiche des Lernzentrums beinhalten eine Bibliothek klinischer Medien, neueste Nachrichten und Artikel aus Fachzeitschriften, Informationen über Veranstaltungen, Leitfäden für Patienten sowie die EACCME-akkreditierte CME-Reihe der europäischen Adipositas-Initiative, mit der insgesamt fünf europäische CME-Fortbildungspunkte (ECMECs) erworben werden können.

,Obesity learning hub header ES

El Centro de aprendizaje sobre obesidad contiene información clínica y recursos para profesionales sanitarios que intervienen en el tratamiento y el manejo de pacientes con obesidad o sobrepeso.
Aquí encontrará un Centro de conocimientos con información sobre epidemiología, fisiopatología, directrices clínicas, opciones de tratamiento y evaluación, métodos de prevención y más. Otras secciones del Centro de aprendizaje incluyen una mediateca clínica, noticias y artículos de revistas, información sobre eventos, guías para pacientes y una serie de EMC de la Iniciativa Europea para la Obesidad acreditada por el EACCME que equivale a un total de cinco créditos de EMC europeos.
 

,Obesity LH Portuguese header

​A Plataforma de Aprendizagem sobre Obesidade contém informações clínicas e recursos para profissionais de saúde envolvidos no tratamento e na gestão de doentes obesos ou com excesso de peso.

Encontrará aqui um Centro de Conhecimento com informações sobre epidemiologia, patofisiologia, orientações clínicas, opções de avaliação e tratamento, métodos de prevenção e mais. Outras secções da Plataforma de Aprendizagem incluem uma mediateca clínica, notícias e artigos de publicações especializadas, informações sobre eventos, guias do doente e a série de FMC da Iniciativa Europeia sobre Obesidade, acreditada pelo EACCME, que equivale a um total de cinco créditos europeus de FMC (ECMEC).
,

Qui troverai un Centro didattico con informazioni su epidemiologia, patofisiologia, linee guide cliniche, opzioni terapeutiche e di valutazione, metodi di prevenzione e tanto altro. Le altre sezioni del Centro di apprendimento comprendono una mediateca clinica, notizie e articoli di giornali, informazioni su eventi, guide per i pazienti e la serie CME European Obesity Initiative accreditata dall’EACCME che vale un totale di cinque crediti ECM europei (ECMEC).

,

This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:

Type 2 Diabetes Mellitus Knowledge Centre: Provides epidemiology statistics, current diagnostic criteria from WHO and ADA, treatment options and a section containing the latest guidelines.

Therapy Focus: Compiles material on emerging insulin/incretin treatment combinations arranged across five informative sections.

‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ CME activity: EACCME-accredited CME activity worth 1 European CME credit (ECMEC).

‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’ CME activityincludes an expert panel discussion video.

,Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial well-being of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC) and should be able to:

  • Describe the psychosocial factors that can affect metabolic control
  • Discuss the rationale and clinical guideline recommendations for psychosocial screening in childhood diabetes
  • Explain the importance of family interactions and dynamics in diabetes management
  • Assess the different behavioural and psychological interventions for optimising diabetes management in children and adolescents
,Obesity Learning Hub

The Obesity Learning Hub contains clinical information and resources for healthcare professionals involved in the treatment and management of obese or overweight patients.

Here you will find a Knowledge Centre with information on epidemiology, pathophysiology, clinical guidelines, assessment and treatment options, prevention methods and more. Other sections within the Learning Hub include a clinical media library, news and journal articles, events information, patient guides and the EACCME-accredited European Obesity Initiative CME series, which is worth five European CME Credits (ECMECs) in total.

,Obesity series

This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.

Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.

Module 2 – Considerations for Individualising Pharmacotherapy
Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care.

Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.

Upon successful completion of these modules, participants will receive a combined total of five European CME credits (ECMECs).

Latest News

Blog

Diabetes care is a hot topic in medicine since it touches so many primary care settings; from maternity to foot care, Diabetes has multiple other pathologies. When does Diabetes care necessitate the role of a specialist? How can diabetologists ensure they work innovatively and make the patient's healthcare journey as seamless as possible? Dr. Partha Kar dives in, asking how healthcare professionals can make positive change to patients with Diabetes in Britain's NHS.

Medical Videos

An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
The Cause of Obesity
The Cause of Obesity
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
Diabetic Macular Edema
Diabetic Macular Edema
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
Peter Attia: What if we're wrong about diabetes?
Peter Attia: What if we're wrong about diabetes?
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.

Recent Drug Updates

Medical Journal Abstracts on Diabetes and Endocrinology

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.

-1 days ago -  Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.

Aims: To compare insulin pump therapy and multiple daily injections (MDI) in patients with type 2 diabetes receiving basal and prandial insulin analogues. Methods: After a 2-month ...

The JAK-STAT Pathway in Obesity And Diabetes.

Sat 12 Mar 2016 -  The JAK-STAT Pathway in Obesity And Diabetes.

Diabetes mellitus is a group of complex, multi-organ metabolic pathologies characterized by hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK-STAT signaling pathway is ...

Clinical Guidelines

Type 2 diabetes: The management of type 2 diabetes

Dec 2015

This guideline contains recommendations for managing type 2 diabetes in adults, and focuses on..

... patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. The guideline does not cover diagnosis, secondary diabetes, type 1 diabetes in adults, diabetes in pregnancy and diabetes in children and young people.

Menopause: diagnosis and management

Nov 2015

This guideline covers the diagnosis and management of menopause, including in women who have..

... premature ovarian insufficiency. The guideline aims to improve the consistency of support and information provided to women in menopause.

Who is it for?
- Healthcare professionals who care for women in menopause.
- Women in menopause, and their families and carers.

The guideline includes recommendations on:
- Individualised care
- Diagnosis of perimenopause and menopause
- Information and advice
- Managing short-term menopausal symptoms
- Long-term benefits and risks of hormone replacement therapy
- Diagnosing and managing premature ovarian insufficiency

Online CME

Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin

Healthcare professionals can enhance their understanding of the combination therapies available for treating type 2 diabetes by completing this free activity. ‘Best Practice in Type 2 Diabetes: Update on Incretin...

Considerations for Individualising Pharmacotherapy

Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care. EACCME accredited.

Understanding Obesity

Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....

Clinical Trials

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (PIONEER 6)

-62 days ago

This trial is conducted globally. The aim of the trial is to investigate the cardiovascular safety of oral semaglutide in subjects with type 2 ...

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

-1 days ago

Primary Objective: To demonstrate that morning injection of Toujeo compared to Lantus will provide better glycemic control evaluated by Continuous Glucose Monitoring (CGM) in adult patients with ...

Back to top